Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women

American Journal of Cardiology

Volumn 110, Issue 7, 2012, Pages 993-1000

  Hung, Chung Lieh ^a,b,c,d   Hung, Ta Chuan ^a,b   Liu, Chun Chun ^a,c   Wu, Yih Jer ^a,e,f   Kuo, Jen Yuan ^a,f   Hou, Charles Jia Yin ^a,b   Yeh, Hung I ^a,f  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d KAINAN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CA 125 ANTIGEN; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; ATRIAL FUNCTION, LEFT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; IMMUNOASSAY; MIDDLE AGED; PROGNOSIS; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84866062331     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.05.030     Document Type: Article

References (27)

1. W.J. Paulus, C. Tschöpe, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, F.E. Rademakers, P. Marino, O.A. Smiseth, G. De Keulenaer, A.F. Leite-Moreira, A. Borbély, I. Edes, M.L. Handoko, S. Heymans, N. Pezzali, B. Pieske, K. Dickstein, A.G. Fraser, D.L. Brutsaert How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550 (Pubitemid 47614269)
2. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259 (Pubitemid 44079340)
3. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, A. Haouzi, Y. Gong, P.P. Liu Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269 (Pubitemid 44088349)
4. C.S.P. Lam, E. Donal, E. Kraigher-Krainer, R.S. Vasan Epidemiology and clinical course of heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 18 28
5. C. Mueller, A. Scholer, K. Laule-Kilian, B. Martina, C. Schindler, P. Buser, M. Pfisterer, A.P. Perruchoud Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647 654 (Pubitemid 38364623)
6. R.S. McKelvie, M. Komajda, J. McMurray, M. Zile, A. Ptaszynska, M. Donovan, P. Carson, B.M. Massie I-Preserve Investigators Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial J Card Fail 16 2010 128 134
7. A.-S. Bargnoux, K. Klouche, J. Fareh, I. Barazer, S. Villard-Saussine, A.-M. Dupuy, H. Leray-Moragues, I. Giuliani, B. Canaud, J.-P. Cristol Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients: correlation with ventricular function, fluid removal and effect of hemodiafiltration Clin Chem Lab Med 46 2008 1019 1024 (Pubitemid 352000496)
8. T. Ichiki, B.K. Huntley, D.M. Heublein, S.M. Sandberg, P.M. McKie, F.L. Martin, M. Jougasaki, J.C. Burnett Jr Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation Clin Chem 57 2011 40 47
9. A. D'Aloia, P. Faggiano, G. Aurigemma, L. Bontempi, G. Ruggeri, M. Metra, S. Nodari, L. Dei Cas Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis J Am Coll Cardiol 41 2003 1805 1811 (Pubitemid 36584256)
10. E. Varol, M. Ozaydin, A. Dogan, F. Kosar Tumour marker levels in patients with chronic heart failure Eur J Heart Fail 7 2005 840 843 (Pubitemid 41125903)
11. F. Kosar, Y. Aksoy, G. Ozguntekin, I. Ozerol, E. Varol Relationship between cytokines and tumour markers in patients with chronic heart failure Eur J Heart Fail 8 2006 270 274 (Pubitemid 44275312)
12. N.T. Kouris, D.D. Kontogianni, E.P. Papoulia, G.S. Goranitou, I.D. Zaharos, H.A. Grassos, E.M. Kalkandi, M.D. Sifaki, D.K. Babalis Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure Hellenic J Cardiol 47 2006 269 274 (Pubitemid 47621130)
13. G. de Simone, R.B. Devereux, M.J. Roman, A. Ganau, P.S. Saba, M.H. Alderman, J.H. Laragh Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension J Am Coll Cardiol 23 1994 1444 1451 (Pubitemid 24158016)
14. G.P. Aurigemma, K.H. Silver, M.A. Priest, W.H. Gaasch Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy J Am Coll Cardiol 26 1995 195 202
15. P. Collier, C.J. Watson, V. Voon, D. Phelan, A. Jan, G. Mak, R. Martos, J.A. Baugh, M.T. Ledwidge, K.M. McDonald Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Eur J Heart Fail 13 2011 1087 1095
16. M.R. Zile, S.M. DeSantis, C.F. Baicu, R.E. Stroud, S.B. Thompson, C.D. McClure, S.M. Mehurg, F.G. Spinale Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure Circ Heart Fail 4 2011 246 256
17. R.A. de Boer, D.J.A. Lok, T. Jaarsma, P. van der Meer, A.A. Voors, H.L. Hillege, D.J. van Veldhuisen Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Ann Med 43 2011 60 68
18. P.A. Canney, M. Moore, P.M. Wilkinson, R.D. James Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker Br J Cancer 50 1984 765 769 (Pubitemid 15221441)
19. T. Seo, Y. Ikeda, H. Onaka, T. Hayashi, K. Kawaguchi, C. Kotake, T. Toda, K. Kobayashi Usefulness of serum CA125 measurement for monitoring pericardial effusion Jpn Circ J 57 1993 489 494 (Pubitemid 23285830)
20. H. Nägele, M. Bahlo, R. Klapdor, D. Schaeperkoetter, W. Rödiger CA 125 and its relation to cardiac function Am Heart J 137 1999 1044 1049 (Pubitemid 30040726)
21. M.B. Yilmaz, A. Zorlu, O.T. Dogan, O. Karahan, I. Tandogan, I. Akkurt Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease Clin Cardiol 34 2011 244 248
22. M.B. Yilmaz, A. Zorlu, I. Tandogan Plasma CA-125 level is related to both sides of the heart: a retrospective analysis Int J Cardiol 149 2011 80 82
23. A.M. Zeillemaker, H.A. Verbrugh, A.A. Hoynck van Papendrecht, P. Leguit CA 125 secretion by peritoneal mesothelial cells J Clin Pathol 47 1994 263 265 (Pubitemid 24120692)
24. M. Epiney, C. Bertossa, A. Weil, A. Campana, P. Bischof CA125 production by the peritoneum: in-vitro and in-vivo studies Hum Reprod 15 2000 1261 1265 (Pubitemid 30335947)
25. V. Melenovsky, B.A. Borlaug, B. Rosen, I. Hay, L. Ferruci, C.H. Morell, E.G. Lakatta, S.S. Najjar, D.A. Kass Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction J Am Coll Cardiol 49 2007 198 207 (Pubitemid 46070209)
26. R.K. Rogers, H.T. May, J.L. Anderson, J.B. Muhlestein Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure Am Heart J 158 2009 777 783
27. B.A. Borlaug, C.S. Lam, V.L. Roger, R.J. Rodeheffer, M.M. Redfield Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction J Am Coll Cardiol 54 2009 410 418